Prophylaxis against covid-19: living systematic review and network meta-analysis.

ABSTRACT:

Updates

This is the second version (first update) of the living systematic review, replacing the previous version (available as a data supplement). When citing this paper please consider adding the version number and date of access for clarity.

Objective

To determine and compare the effects of drug prophylaxis on severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (covid-19).

Design

Living systematic review and network meta-analysis (NMA).

Data sources

World Health Organization covid-19 database, a comprehensive multilingual source of global covid-19 literature to 4 March 2022.

Study selection

Randomised trials in which people at risk of covid-19 were allocated to prophylaxis or no prophylaxis (stand

SUBMITTER: Bartoszko JJ 

PROVIDER: S-EPMC8073806 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature